UNSPSC 51451704: Thenium closylate

This classification denotes an antihelminthic agent with the molecular formula C15H20NOS.C6H4ClO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TU308VI4JY, chemically known as 2-thiophenemethanaminium, n,n-dimethyl-n-(2-phenoxyethyl)-, salt with 4-chlorobenzenesulfonic acid (1:1) but generally known as thenium closilate, which bears US NIH Compound Identifier 20293. European Medicines Agency schedules Thenium closilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10961MIG.

The term THENIUM CLOSILATE is an International Non-Proprietary Name. As of Q4 2014, THENIUM CLOSYLATE remains the US FDA Preferred Term for this commodity. Thenium closylate bears US NLM identifiers UMLS ID C0521914 and NCI Concept Code C84199. SMILES: C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CS2.C1=CC(=CC=C1S(=O)(=O)[O-])Cl.

UNSPSC 51451704 Thenium closylate is a Commodity code whose recent posting activity shows limited direct relevance to the nominal product specification. The recent opportunities tagged to this code actually span naloxone procurement, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products distributed through established wholesaler networks—a far broader scope than a single pharmaceutical compound. State and local issuers are buying emergency medical supplies, prescription fulfillment systems, and commoditized generic drugs and OTC items through various mechanisms: sealed bids for fire-rescue consumables, RFIs for alternative pharmacy contracting models, and RFPs for cooperative purchasing of pharmaceuticals via authorized wholesaler channels. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (MMCAP, administered by Minnesota).

Recent activity concentrates in Florida, Texas, and Minnesota, with MMCAP extending into Oregon and other member states. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (posted June 30, 2026, due July 26, 2023); the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 with a certified Small Local Business Enterprise set-aside and 5% bid discount (posted March 25, 2026, due March 13, 2026); the Texas Health and Human Services Commission's RFI on Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions (posted April 3, 2026, deadline April 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (posted January 20, 2026, due March 26, 2026, effective July 1, 2026). The code shows substantial activity but the tagged opportunities diverge significantly from the product name, signaling either miscoding or a data quality gap that warrants clarification before pursuit.